6.9K
Downloads
9
Episodes
By Jason L. Crowell, MD Jerome H. Grossman MD Graduate Fellow, Harvard Kennedy School Neurologist, Beth Israel Deaconess Medical Center; Steve Pearson, Founder and President, ICER, Lecturer, Department of Population Medicine, Harvard Medical School
Episodes
Monday Nov 23, 2020
Monday Nov 23, 2020
What motivates a drug manufacturer to create a drug in the first place? How do firms stretch the limits of these incentives? In episode 4, we discuss how the “ecosystem” of drug development in the US has led to truly remarkable innovation but also runaway drug prices.
No comments yet. Be the first to say something!